WASHINGTON—Republicans are calling on the Department of Health and Human Services to take &#8220;immediate action&#8221; to reinstate safety requirements on abortion drugs, highlighting a growing body of evidence showing that the drugs are causing severe and underreported harm to women.
In a letter first obtained by The Daily Wire, New Jersey Rep. Christopher Smith and Tennessee Rep. Diana Harshbarger call on Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary to &#8220;at a minimum, reinstate the in-person dispensing requirement for mifepristone.&#8221; Until 2023, the FDA required abortion drugs to be administered to women under a doctor&#8217;s supervision.
&#8220;The need for urgent investigation and review of this drug comes in the wake of the Biden-Harris administration’s egregious action to remove critical safeguards that once applied to abortion drugs, and the FDA’s approval of a new abortion drug generic in September 2025,&#8221; write the 175 lawmakers, including House Speaker Mike Johnson (R-LA), Majority Leader Steve Scalise (R-LA), and Majority Whip Tom Emmer (R-MN).
&#8220;Under your leadership, HHS and FDA can reverse this wrong,&#8221; they conclude. &#8220;We urge you to immediately reinstate the REMS requiring in-person dispensing of mifepristone and to expedite the promised review by the FDA into the dangers of abortion drugs.&#8221;
The move is significant since President Joe Biden&#8217;s administration green-lit the removal of safety standards on the drugs during the COVID-19 pandemic, allowing women to easily obtain the drugs at home. Pro-life advocates have long argued that women are being put in danger simply from taking the abortion drugs, but they are even more anxious about women taking the drugs on their own.
New studies are showing that complications are &#8220;astonishingly higher than what is reported on the drug’s label,&#8221; the lawmakers say: &#8220;Even the current Obama FDA-approved label for mifepristone — which the data show understates the dangers to women — says that roughly 1 in 25 women who use mifepristone as directed will end up in the emergency room.&#8221;
“We join House and Senate Republicans in calling on the FDA to – at a minimum – immediately end Joe Biden’s legacy of mail-order abortion and restore the in-person doctor requirement that existed during President Trump’s first administration,&#8221; said SBA Pro-Life America&#8217;s head, Marjorie Dannenfelser. &#8220;<a href="https://sbaprolife.org/newsroom/press-releases/breaking-7-in-10-voters-want-to-roll-back-biden-covid-abortion-drug-policy-reinstate-in-person-doctor-visits">Seven in 10</a> voters agree. We are deeply grateful to Reps. Chris Smith and Diana Harshbarger for leading this important letter, and to House leadership and every member of Congress who joined in standing for women and their unborn children.&#8221;
Meanwhile, abortion proponents and legacy media insist the drugs are safer than Tylenol. President Donald Trump&#8217;s administration has weighed the issue carefully, cognizant of how electorally delicate abortion is. And in early October, the FDA approved a new abortion pill, shocking the president&#8217;s <a href="https://www.dailywire.com/news/pro-lifers-demand-answers-from-trump-admin-after-shocking-abortion-pill-approval">pro-life supporters.</a>
At the time, Kennedy put out a statement clarifying that he understood that the Biden administration had removed mifepristone&#8217;s safety standards &#8220;without studying the safety risks.&#8221;
&#8220;We are filling that gap,&#8221; he promised, sharing that he and Makary wrote to state attorneys general and promised to &#8220;review all the evidence — including real-world outcomes — on the safety of this drug.&#8221;
<blockquote class="twitter-tweet">
The Biden administration removed mifepristone’s in-person dispensing rule without studying the safety risks. We are filling that gap. Last month, I joined <a href="https://twitter.com/DrMakaryFDA?ref_src=twsrc%5Etfw">@DrMakaryFDA</a> in writing to state attorneys general, pledging to review all the evidence — including real-world outcomes — on… <a href="https://t.co/G0eE4H4y42">pic.twitter.com/G0eE4H4y42</a>
— Secretary Kennedy (@SecKennedy) <a href="https://twitter.com/SecKennedy/status/1973866621245567344?ref_src=twsrc%5Etfw">October 2, 2025</a></blockquote>
Right now, DailyWire+ annual memberships are fifty percent off during our Black Friday sale. Join now at <a class="c-link c-link--focus-visible c-link--underline" href="http://dailywire.com/blackfriday" target="_blank" rel="noopener noreferrer" data-stringify-link="http://dailywire.com/blackfriday" data-sk="tooltip_parent">dailywire.com/blackfriday</a>.
&#8220;Recent studies already point to serious risks when mifepristone is used without proper medical oversight,&#8221; he said, and he clarified of the new abortion pill that that the FDA just approved: &#8220;[The FDA] only approved a second generic mifepristone tablet because federal law requires approval when an application proves the generic is identical to the brand-name drug.&#8221;
In their appeal, the Republican lawmakers express gratitude to Kennedy and Makary for serving the most pro-life president in American history, saying that Trump has &#8220;done more to advance a culture of life and the protection of women and children from the violence of abortion than any president before him.&#8221; But they also cite polling from McLaughlin and Associates that found that 7 in 10 voters agree that it &#8220;makes sense&#8221; to bring the former FDA safety standards back, arguing that &#8220;clear majorities of Americans recognize the extreme overreach of the previous administration’s actions.&#8221;
The lawmakers also dive into how the abortion drugs affect mothers, citing an Ethics and Public Policy Center study showing the adverse events from mifepristone are about 22 times more frequent than the FDA recognizes. That study found that almost 11% of women experience sepsis, infection, hemorrhaging, or other life-threatening events after aborting their unborn baby with mifepristone.
&#8220;While we have long known that mifepristone causes the death by starvation of children alive in the womb — it is baby poison — we now know with greater certitude that their mothers are also being seriously harmed. Despite the mainstream media and the Biden-Harris administration perpetuating the lie that these drugs are &#8216;safer than taking a Tylenol,&#8217; science and women’s lived experiences clearly say otherwise.&#8221;
And while the Biden administration claimed that the removal of safety standards was in response to the COVID pandemic, to help women receive &#8220;medically necessary&#8221; care, the lawmakers argue that the former administration was really just using COVID as a &#8220;smokescreen&#8221; to &#8220;accomplish its radical abortion agenda, which even now wreaks havoc across the nation.&#8221;
&#8220;Even the current Obama FDA-approved label for mifepristone — which the data show understates the dangers to women — says that roughly 1 in 25 women who use mifepristone as directed will end up in the emergency room,&#8221; they write.
They also say that the Biden FDA ignored warning signs from the studies on which it had already relied, including data showing that 3% of the women who took the drugs need to be hospitalized, &#8220;a 330% increase over the rate on the approved drug label,&#8221; data showing that 6% of participants had unplanned visits to emergency rooms, surgery was required to complete the abortions for 4.1% of the women, and, in the telemedicine group, 5.8% of women had emergency room visits.
&#8220;Beyond the studies, women tell us how they have suffered harm from mifepristone, and stories of coercion and abuse involving abortion drugs now run rampant,&#8221; they continue. &#8220;Real women like Rosalie Markezich — who is just one example of many — felt coerced by her boyfriend to take abortion drugs that he ordered from an out-of-state prescriber in her name and had delivered to her home through the U.S. Postal Service.&#8221;
&#8220;Rosalie did not want to have an abortion, but Biden’s egregious weakening of mifepristone’s safety standards let her boyfriend obtain abortion drugs and force her to take them,&#8221; they argue. &#8220;The dangerous Biden mail-order scheme was designed to give abortion activists license to mail drugs everywhere, even into states like Markezich’s home state of Louisiana that have pro-life protections for pregnant mothers and their unborn babies.&#8221;
&#8220;Today, abortion drugs account for nearly two-thirds of all abortions in the United States; there are over six hundred thousand abortions committed using these drugs each year,&#8221; the lawmakers write. &#8220;The Biden FDA’s reckless, no-contact, mail-order abortion scheme is to blame. Abortion providers are reaping increased profits, while women and their unborn children suffer irreparable harm.&#8221;

Illustrated by Daily Wire

‘Reverse This Wrong’: Republicans Push RFK To Fix Biden’s Abortion Drug Mistakes

Abortion

Robert F. Kennedy Jr.

White House

Americans are finding common ground on an unexpected issue, abortion drugs. <a href="https://sbaprolife.org/newsroom/press-releases/breaking-7-in-10-voters-want-to-roll-back-biden-covid-abortion-drug-policy-reinstate-in-person-doctor-visits">New polling</a> shows that rolling back dangerous Biden-era policies on the drugs is not only supported by a majority of Americans, but such support transcends traditional party divides and the “pro-life” versus “pro-choice” label.
Seven in 10 likely voters <a href="https://sbaprolife.org/wp-content/uploads/2025/10/National-Voter-Survey-Executive-Summary-.pdf">approve</a> of reinstating safeguards around the drugs by requiring a doctor visit for abortion drug prescriptions. Even more revealing, the majority of voters who were surveyed for the poll identify as “pro-choice,” representing a possible shift in how voters view the repercussions of the drugs for women’s health and safety.
Another 70% of respondents support doctors screening for and reporting possible abuse and coercion before prescribing the drugs, a policy that could have prevented the tragedy <a href="https://www.nbcnews.com/news/us-news/texas-attorney-poisoned-pregnant-wife-abortion-medication-sentenced-18-rcna138065">Catherine Herring</a> experienced firsthand when her husband purchased lethal abortion drugs online and tried to end her pregnancy by lacing her drinks.
Catherine’s abuser was enabled by the Biden Administration’s removal of abortion drug safeguards, which eliminated in-person dispensing requirements for abortion pills under the Risk Evaluation and Mitigation Strategy (REMS) program. As a result, it’s easier than ever for would-be abusers and coercers to obtain the pills via mail. The FDA’s recent approval of a new generic version of the abortion drug mifepristone only compounds these risks for women by making the drugs even easier to access.
The response has been swift, with groups urging the FDA to rescind their approval and restore policies that protect women’s health and safety while affirming life.
The dangers of abortion drugs have never been more apparent. A recent <a href="https://eppc.org/news/largest-ever-study-of-abortion-pill-reveals-shocking-number-of-adverse-events/">study</a> from the Ethics and Public Policy Center found that serious adverse events from the abortion drug are approximately 22 times more frequent than the FDA currently reports, with over one in ten women experiencing sepsis, infection, hemorrhaging, or other harmful side-effects.
A peer-reviewed <a href="https://www.mdpi.com/2673-6284/14/2/39">article</a> from the Charlotte Lozier Institute also debunked the popular claim that the abortion pill is “safer than Tylenol.” Just recently, the American Association of Pro-Life OBGYNs (AAPLOG) <a href="https://aaplogaction.org/wp-content/uploads/2025/08/2025.08.20-One-Pager-Clostridial-Infection-after-Mifepristone.pdf">sounded the alarm</a> on a dangerous sepsis-like infection that can occur after a pregnant woman takes mifepristone.
Even Health and Human Services Secretary Robert F. Kennedy Jr. publicly <a href="https://news.bloomberglaw.com/health-law-and-business/rfk-jr-says-biden-twisted-the-data-on-abortion-pill-safety">admitted</a> that the Biden Administration had “twisted the data to bury one of the safety signals, a very high safety signal, around 11 percent” related to abortion drugs. Yet the FDA significantly expanded access to mifepristone with the approval of the new generic pill, rather than pausing to examine the current evidence of harm or complete the agency’s <a href="https://www.cbsnews.com/news/rfk-fda-abortion-pill-mifepristone-safety-review/">promised report</a> on the safety of the drug.
In any other area of medicine, such findings would have triggered alarm, inquiry, and reform. In the absence of any such immediate action, the pro-life movement, state attorneys general, and Congress are standing in the gap to protect women.
A <a href="https://www.liveaction.org/news/coalition-hhs-fda-pull-abortion-pill-approval">coalition</a> of advocacy and policy organizations – led by Live Action with support from Students for Life, Concerned Women for America, Heartbeat International, Advancing American Freedom, AAPLOG, the Life Leadership Conference, and several others – joined with state leaders to demand a reversal of the FDA&#8217;s decision to approve the new generic version of mifepristone.
Attorney generals from twenty-two states, led by Alabama’s Steve Marshall, <a href="https://www.alabamaag.gov/attorney-general-steve-marshall-condemns-the-fdas-illegal-and-dangerous-decision-to-abandon-restrictions-on-abortion-inducing-drugs/#:~:text=%E2%80%9CIn%20direct%20contravention%20of%20longstanding,terms%20for%20%E2%80%9Cprioritizing%20.%20.%20.">denounced</a> the FDA’s “illegal and dangerous” rollback of in-person dispensing rules. Fifteen more have <a href="https://thehill.com/policy/healthcare/5427732-republican-states-target-abortion/">called on Congress</a> to confront “shield laws” that allow doctors to mail abortion drugs into pro-life states while circumventing state laws.
Earlier this month, Senator Lindsey Graham led 51 senators in sending a <a href="https://www.lgraham.senate.gov/public/index.cfm/2025/10/51-republican-senators-urge-fda-to-continue-to-stand-for-life-reevaluate-generic-abortion-pill-approval">joint letter</a> to Secretary Kennedy and FDA Commissioner Marty Makary, urging them to halt the rollout of the new generic drug and reinstate the safety rules that once governed its use.
Senate HELP Committee Chair Bill Cassidy followed with an <a href="https://sbaprolife.org/newsroom/press-releases/help-committee-chairman-cassidy-leads-critical-oversight-effort-on-abortion-drugs">oversight letter</a> pressing the same officials to explain how the agency could expand access while simultaneously pledging to “review the ongoing data.” Cassidy warned that the FDA’s decision “fails to mitigate the risks to women that have been identified and fails to protect women from the coercive use of the drug.”
The central claim is simple: women’s health and safety are on the line. The FDA and HHS must act to restore crucial safeguards.
Pro-life groups and elected officials echo the voices of women who have been harmed directly by abortion drugs. Women like <a href="https://eppc.org/wp-content/uploads/2025/08/1-Complaint-8.11.2025_compressed.pdf">Liana Davis</a>, whose hot chocolate was laced with abortion drugs by her boyfriend, resulting in a miscarriage; <a href="https://www.liveaction.org/news/victim-coerced-mail-order-abortion-suing-fda">Rosalie Markezich,</a> who was coerced by her boyfriend into taking mail-order abortion pills; and <a href="https://www.nbcnews.com/news/us-news/texas-attorney-poisoned-pregnant-wife-abortion-medication-sentenced-18-rcna138065">Catherine Herring,</a> who unknowingly consumed abortion drugs slipped into her drink by her husband.
Their heartbreaking stories shine a light on the true costs of uncontrolled abortion drugs. Americans understand those costs too, and a majority want to see crucial safeguards restored. The FDA and HHS must respond and act before more women are harmed.
* * *
<a href="https://x.com/davidbereit">David Bereit</a> is the executive director of the Life Leadership Conference.
The views expressed in this piece are those of the author and do not necessarily represent those of The Daily Wire.
Correction: The image for this article has been replaced and the second paragraph was updated for accuracy.

Wyoming’s Only Abortion Clinic Forced To Stop Administering Abortions Due To New State Law

The Bipartisan Backlash Against Mail-Order Abortion Pills

Abortion Drug

Live Action

Mifepristone

Pregnancy

Pro-Life Movement

Women

The House races to vote on a resolution that could end the government shutdown, the FDA removes black box warnings for hormone replacement therapy drugs, and we look at the role media bias played in shaping Americans’ views on the shutdown.
It’s Wednesday, November 12, 2025, and this is the news you need to know to start your day. Today’s edition of the Morning Wire podcast can be heard below, and <a href="https://www.dailywire.com/episode/mrn-251112-member-exclusive">the video version can be seen on The Daily Wire</a>:
<iframe style="width: 100%; max-width: 660px; overflow: hidden; border-radius: 10px;" src="https://embed.podcasts.apple.com/us/podcast/shutdown-nears-end-black-box-warning-reversed-11-12-25/id1576594336?i=1000736400803" height="175" frameborder="0" sandbox="allow-forms allow-popups allow-same-origin allow-scripts allow-storage-access-by-user-activation allow-top-navigation-by-user-activation"></iframe>
<h2 style="text-align: center;">House Shutdown Vote?</h2>
<img loading="lazy" decoding="async" class="alignnone size-medium wp-image-999521" src="https://dw-wp-production.imgix.net/2025/11/House-Shutdown-Vote-300x169.jpg" alt="" width="300" height="169" srcset="https://dw-wp-production.imgix.net/2025/11/House-Shutdown-Vote-300x169.jpg 300w, https://dw-wp-production.imgix.net/2025/11/House-Shutdown-Vote-1024x576.jpg 1024w, https://dw-wp-production.imgix.net/2025/11/House-Shutdown-Vote-768x432.jpg 768w, https://dw-wp-production.imgix.net/2025/11/House-Shutdown-Vote-1536x864.jpg 1536w, https://dw-wp-production.imgix.net/2025/11/House-Shutdown-Vote.jpg 1920w" sizes=" (max-width: 300px) 100vw, 300px" />
Topline: The government shutdown appears to be on the verge of finally ending, as both parties debate the future of healthcare, and Sen. Chuck Schumer (D-NY) fends off calls for his resignation.
The federal government may finally reopen on Wednesday. The bill broke through the Senate with the help of eight Democrats. That bill will now go to the House, and it is expected to begin voting today at around 4:00 p.m. ET.
This is a major development following the longest government shutdown in American history, and it comes at a time when D.C. is deeply politically divided. There has been a lot of pushback, not only against the Democrats who voted to reopen the government, but also against Minority Leader Schumer, who is now facing calls to step down or even be primaried in 2028.
What does D.C. do next? Once the government is back in operation, the focus will shift back to healthcare, but the debate will look different. During the shutdown, Democrats said they wanted the continuing resolution to be contingent upon continuing subsidies for Obamacare. Now, as part of the Senate deal, Democrats want to bring that discussion back next month, since the government will only be funded through the end of January if the bill passes. The shutdown debate could flare up again if lawmakers don&#8217;t figure this out before funding runs out.
If the subsidies don&#8217;t continue, opponents have said that a coming premium spike is proof that the Affordable Care Act was not sustainable in the first place.
House Speaker Mike Johnson (R-LA) has said that this deal was the Senate’s, and that the House didn&#8217;t make any promises on its end, so there hasn&#8217;t been a commitment yet to finding a solution to Obamacare subsidies.
Trumpcare: There has been discussion on tax-advantaged Health Savings Accounts. President Donald Trump has also floated giving some of the subsidy money back to the American people. Trump has argued that many of these subsidies only benefited large insurance companies.
“Instead of going to the insurance companies, I want the money to go into an account for people where the people buy their own health insurance. If we did that, that would be so exciting. Call it Trumpcare,” the president <a href="https://x.com/_johnnymaga/status/1988038828846670192?s=20">said</a>.
<h2 style="text-align: center;">HRT Black Box Warning Axed</h2>
<img loading="lazy" decoding="async" class="alignnone size-medium wp-image-999519" src="https://dw-wp-production.imgix.net/2025/11/22Black-Box22-Warning-Axed-300x169.jpg" alt="" width="300" height="169" srcset="https://dw-wp-production.imgix.net/2025/11/22Black-Box22-Warning-Axed-300x169.jpg 300w, https://dw-wp-production.imgix.net/2025/11/22Black-Box22-Warning-Axed-1024x576.jpg 1024w, https://dw-wp-production.imgix.net/2025/11/22Black-Box22-Warning-Axed-768x432.jpg 768w, https://dw-wp-production.imgix.net/2025/11/22Black-Box22-Warning-Axed-1536x864.jpg 1536w, https://dw-wp-production.imgix.net/2025/11/22Black-Box22-Warning-Axed.jpg 1920w" sizes=" (max-width: 300px) 100vw, 300px" />
Topline: The FDA is removing “black box” warnings from hormone replacement therapy for menopause symptoms. The reversal is earning high praise from both the medical establishment and medical outsiders. 
The warnings were slapped on HRT for menopausal and perimenopausal women more than two decades ago by the FDA. But FDA Commissioner Marty Makary says those warnings were unnecessary, harmful, and based on a significantly flawed 2002 Women’s Health Initiative study that connected this treatment to an increase in breast cancer risk.
Why it matters: While currently fewer than 5% of menopausal women take HRT, Dr. Makary says between 50 and 70 million women have been denied or discouraged from taking the treatment since that study was mainstreamed. Makary also says the vast majority of those women were denied life-changing or even life-saving treatment. 
“Women who go through menopause and start hormone replacement therapy have profound short-term and long-term health benefits, including reducing the risk of bone fractures by 50-60% later in life, reducing the risk of fatal heart attacks by 30-50%,” Makary told Morning Wire. “That&#8217;s the number one cause of death in women – and reducing cognitive decline. There may be no medication in the modern era, aside from perhaps antibiotics or vaccines, that can improve the health outcomes of women on a population level more than hormone replacement therapy started within 10 years of the onset of menopause.”
Makary noted that this treatment is for the vast majority of women in this phase of life, though he said there are rare exceptions to that, for example, if a woman currently has breast cancer. Women should talk to their doctors before receiving treatment.
View from the experts: Major medical groups are supporting this. The American College of Obstetricians and Gynecologists (ACOG), which represents more than 60,000 physicians and medical professionals, praised the FDA for empowering women.
The Menopause Society, the American Association of Clinical Urologists, and the National Consumers League, a consumer advocacy organization, also applauded this change from the FDA. Also of note, <a href="https://magazine.hms.harvard.edu/articles/how-gender-bias-medicine-has-shaped-womens-health?utm_source=chatgpt.com">Harvard Medicine Magazine</a> last year acknowledged that this Women’s Health Initiative study “has widely been considered flawed.”
<h2 style="text-align: center;">Democrat-Media Complex</h2>
<img loading="lazy" decoding="async" class="alignnone size-medium wp-image-999517" src="https://dw-wp-production.imgix.net/2025/11/Media-Shutdown-Slant-300x169.jpg" alt="" width="300" height="169" srcset="https://dw-wp-production.imgix.net/2025/11/Media-Shutdown-Slant-300x169.jpg 300w, https://dw-wp-production.imgix.net/2025/11/Media-Shutdown-Slant-1024x576.jpg 1024w, https://dw-wp-production.imgix.net/2025/11/Media-Shutdown-Slant-768x432.jpg 768w, https://dw-wp-production.imgix.net/2025/11/Media-Shutdown-Slant-1536x864.jpg 1536w, https://dw-wp-production.imgix.net/2025/11/Media-Shutdown-Slant.jpg 1920w" sizes=" (max-width: 300px) 100vw, 300px" />
Topline: With the government shutdown poised to end on a sour note for most Democrats, it has become painfully obvious just how eager some in the media were to put their thumbs on the scales. 
The legacy media coverage was biased against Republicans over the shutdown, and the numbers prove it. The Media Research Center conducted a study of the first full month of the shutdown, from October 1 to October 31. It looked at the evening news broadcasts on the three major networks – ABC, CBS, and NBC – and discovered that 87% of the network news coverage during that time had been skewed in favor of the Democrats.
The center evaluates only the statements made by anchors and experts who are supposed to be nonpartisan, which would exclude comments from elected Democrats or Republicans, or from pundits who are decidedly partisan. Using that framework, it found 83 statements about the shutdown that were critical of Republicans and only 12 that were critical of Democrats.
Those same people, despite discussing the shutdown on multiple broadcasts, showed very little interest in discussing why the government was shut down or who repeatedly voted against the clean continuing resolution that would have reopened the government. According to the center, “On both ABC and CBS, only 12.5 percent of reports on either network mentioned this basic detail. On NBC, that fact was included in just 31 percent of newscasts.”
View from the media: On CNN, the network is laying it on thick against Schumer and highlighting the blowback against him within his own party. CNN pollster Harry Enten sounded off: “ What about Democrats nationwide feeling about Chuck Schumer? I think the word of the day is terrible, terrible, terrible, terrible.”
The hosts of ABC’s “The View” have been gunning for Schumer since March because, as they said, he “caved” to avoid a shutdown early in Trump’s term. They re-upped calls for him to step aside on Monday, and on Tuesday, they spent some time yelling at Pennsylvania Democratic Sen. John Fetterman for voting in favor of his constituents not starving.
There’s a bit of a pile-on effect happening right now. The argument appears to be that the compromise has given President Trump yet another win, which is something Democrats and many in the legacy media hate to do.

MRN_251112_V1

Morning Brief: House Vote On Shutdown, Women’s Health Gets A Reboot, & Media Blames Usual Suspects

Morning Brief: Shutdown Showdown, Women's Health Gets A Reboot, & Media Blames The Usual Suspects

Chuck Schumer

Government Shutdown

House of Representatives

Media

Media Research Center

Mike Johnson

Morning Wire

Politics

Senate

More than a dozen Democrat governors have signed on to a new health alliance that is effectively meant to challenge the Trump administration&#8217;s health agencies.
The Governors&#8217; Public Health Association, which was created last week, seeks to dole out medical guidance that will likely be at odds with the Trump administration&#8217;s Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA). It will make recommendations on vaccines and other public health measures, and work with allied states to share medical statistics and data. 
It&#8217;s been pitched as “non-partisan” and science- and health-backed, and a way to restore public trust. However, only Democrat governors have signed on to the initiative. So far, those states include California, Illinois, Colorado, Connecticut, Delaware, Hawaii, Maryland, Massachusetts, New Jersey, New York, North Carolina, Oregon, Rhode Island, Washington, and the territory of Guam.
Health and Human Services (HHS) spokesman Andrew Nixon has <a href="https://apnews.com/article/governors-public-health-alliance-kennedy-7d5f277178697bbdfc228567c6d9f616">called</a> out the allied Democrat governors for imposing school closures and mask mandates, even for toddlers, during the pandemic. He asserted that they are the ones who “destroyed public trust in public health&#8221; &#8212; not the Trump administration.
Join us now during our exclusive Deal of the Decade. Get everything for $7 a month. Not as fans. As fighters. Go to <a href="https://get.dailywire.com/subscribe/plus/" target="_blank" rel="noopener">DailyWire.com/Subscribe</a> to join now.
 Nixon added that Trump and HHS Secretary Robert F. Kennedy Jr. are rebuilding that trust &#8220;by grounding every policy in rigorous evidence and Gold Standard Science – not the failed politics of the pandemic.”
Illinois Gov. JB Pritzker (D) unsurprisingly signed on to the Governors&#8217; Public Health Association, and has <a href="https://gov-pritzker-newsroom.prezly.com/gov-pritzker-joins-launch-of-governors-public-health-alliance-to-protect-illinoisians-from-trumps-attack-on-science?">claimed</a> it’s a necessary body since &#8220;public health should never be politicized.” Trump and RFK, he claims, have turned the CDC “into a misinformation machine.”
Fellow Democrat, California Gov. Gavin Newsom, similarly emphasized that science should be put before politics. Newsom, who <a href="https://sd11.senate.ca.gov/news/senator-wieners-historic-bill-provide-refuge-trans-kids-and-their-families-signed-law">supports</a> sex changes for minors based on &#8220;gender identity,&#8221; added that “extremists” are trying to “weaponize the CDC and spread misinformation.”
The association is primarily funded by a nonprofit called Governors Action Alliance, known as GovAct. The nonprofit claims to be nonpartisan, but supports Democrat causes and generally teams up with Democrats to expand Medicaid and bolster so-called abortion and voting rights.
Notably, GovAct is behind the “Reproductive Freedom Alliance,&#8221; which is a coalition of Democrat governors working to expand abortion. The nonprofit dumped more than half a billion dollars into the initiative. It’s also behind the “Governors Safeguarding Democracy” alliance, which was launched to resist Trump shortly after he won the 2024 election.
The goal of the Governors&#8217; Public Health Association is seemingly to undermine the FDA and CDC with heavy focus on vaccine and abortion “access.&#8221; 
This will, however, come with complications for Democrats. States have to comply with certain federal health guidance or standards if they want federal funding. Additionally, health insurers generally follow federal guidance for their coverage, and large health insurers operate in multiple states if not nationwide. It would be chaotic and impractical to implement different sets of standards in different states.
Opposing guidance could also trigger legal battles. For example, the FDA is currently reviewing the safety of a controversial abortion pill called mifepristone. If there were some determination that the governors&#8217; alliance disagreed with, that could potentially set up a legal challenge.

Pritzker/RFK Jr.

Dem Govs Create Association To Challenge CDC, FDA In Name Of ‘Science’ And Health

Democrats

Health

The U.S. Food and Drug Administration confirmed on Friday that toxic cough syrups linked to children&#8217;s deaths in India had not been shipped to the United States.
The World Health Organization has said India has a &#8220;regulatory gap&#8221; in screening locally sold syrup medicines.
The U.S. FDA said it was aware of news reports of devastating, ongoing diethylene glycol and ethylene glycol contamination in children&#8217;s cough and cold medicine in India.
Indian authorities advised the public to avoid two more brands of cough syrup on Wednesday following the deaths of 17 children under age five, linked to a toxic ingredient.
<a href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout</a>
The children died in India over the past month after consuming cough medicine containing toxic diethylene glycol in quantities nearly 500 times the permissible limit, officials said. The deaths were all linked to the Coldrif medicine brand, which was banned after a test confirmed the presence of the chemical on October 2.
India&#8217;s health authority, the Central Drugs Standard Control Organization, informed the U.S. regulator that these products were not exported from India to any other country, the FDA said.
The FDA also said it remains vigilant to prevent contaminated drugs from entering the U.S. and asked manufacturers to ensure that drugs marketed in the U.S. are safe and of the highest quality.
(Reporting by Sneha S K in Bengaluru; Editing by Pooja Desai)

Cough Syrup

Cough Syrups Linked To Child Deaths Not Shipped To U.S., FDA Makes Clear

India

Prescription Drugs

World

Louisiana sued the FDA this week for allowing the unfettered mailing of abortion drugs across the country.
The suit, <a href="https://storage.courtlistener.com/recap/gov.uscourts.lawd.213952/gov.uscourts.lawd.213952.1.0.pdf">filed</a> Monday by Louisiana Attorney General Liz Murrill, accused the FDA of enabling leftist activists to mail abortion pills into states like Louisiana, where chemical abortions are illegal. Murrill asked the court to strike down the FDA’s approval during the Biden administration of mail-order abortion pills.
“Every year, doctors and activists in states like California and New York mail a U.S. Food and Drug Administration (FDA)-approved abortion drug called mifepristone to thousands of Louisiana residents for the express purpose of causing abortions in Louisiana that are blatantly unlawful,” the suit said. “This extra-territorial mailing of abortion drugs is illegal under state law—and it is the direct result of the Biden Administration’s 2023 agency action expressly facilitating this scheme. That action is the subject of this lawsuit.”
In 2023, the Biden administration changed the Risk Evaluation Mitigation Strategy (REMS) for mifepristone, the drug used in over 60% of all abortions, allowing it to be sent through the mail.
Mifepristone works by starving an unborn child to death by cutting it off from the necessary nutrients provided by its mother. A different drug is then taken to induce labor and expel the deceased baby.
Murrill argued in the suit that the FDA’s regulations for mifepristone are “arbitrary and capricious” and violate the Comstock Act, a federal law that bans the mailing of abortion drugs. Joining the suit was Rosalie Markezich, a woman who says her boyfriend ordered illegal abortion pills from California and was then pressured into taking them to end the life of her unborn child.
<a href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial" target="_blank" rel="noopener">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout!</a>
In response to a request for comment on the suit, the Department of Health and Human Services said that it does not comment on pending litigation. HHS did point The Daily Wire to its commitment to conducting a study on the reported adverse effects of mifepristone.
“The Biden administration removed mifepristone’s in-person dispensing rule without studying the safety risks. We are filling that gap. Last month, I joined [FDA Commissioner Marty Makary] in writing to state attorneys general, pledging to review all the evidence — including real-world outcomes — on the safety of this drug. Recent studies already point to serious risks when mifepristone is used without proper medical oversight,” HHS Secretary Robert F. Kennedy Jr. <a href="https://x.com/SecKennedy/status/1973866621245567344">said</a> earlier this month.
The suit comes after pro-life advocates were <a href="https://www.dailywire.com/news/pro-lifers-demand-answers-from-trump-admin-after-shocking-abortion-pill-approval?author=Leif+Le+Mahieu&amp;category=News&amp;elementPosition=undefined&amp;row=0&amp;rowType=Vertical+List&amp;title=Pro-Lifers+Demand+Answers+From+Trump+Admin+After+‘Shocking’+Abortion+Pill+Approval">shocked</a> last week after the FDA approved a new generic mifepristone pill. Fifty-two Republican senators sent a <a href="https://justthenews.com/sites/default/files/2025-10/2025.10.09%20-%20Letter%20from%20Senator%20Graham%20et%20al%20to%20HHS%20and%20FDA%20re%20Mifepristone.pdf">letter</a> on Thursday to the FDA and HHS urging them to scrap the regulations that allow the mailing of abortion drugs.
The FDA has said that it was required by law to approve the new generic drug and noted that it was conducting a review of the Biden guidelines. On a press call on Wednesday, SBA Pro-Life America President Marjorie Dannenfelser said she was skeptical of that reasoning.
“This standard only seems to apply to this particular drug. It [has] certainly not been the standard for other drugs where there were questions that needed to be asked, that needed to get answers from those that were developing the drugs,” she said.

Appeals Court Keeps Abortion Pill Mifepristone Available, But With Restrictions

‘Blatantly Unlawful’: Red State Challenges FDA Over Mail-Order Abortions

Biden Administration

Department of Health and Human Services

Louisiana

Social Issues

U.S.

Last month marked 25 years since the Food and Drug Administration approved the abortion drug mifepristone, then called RU-486, for use in the United States.
On September 19, Health and Human Services Secretary Robert F. Kennedy, Jr., and the FDA Commissioner Marty Makary, sent a letter to 22 pro-life state attorneys general informing them that the agencies will perform a review of the drug’s safety.
Such a review is long overdue and should result in the revocation of the FDA’s approval of mifepristone or, at minimum, the restoration of important protections around the drug’s prescription.
Since sending that letter, the FDA unexpectedly approved a generic form of the chemical abortion drug. RFK, Jr., and Dr. Makary have regulatory tools at their disposal that could begin the process of removing these dangerous drugs from the market. It is time for them to take decisive action.
The FDA first approved mifepristone in 2000 under a regulation known as Subpart H which allows for the expedited approval of drugs that treat “serious or life-threatening illnesses” and that provide a “meaningful therapeutic benefit to patients over existing treatments.” Mifepristone meets neither of these requirements.
First, mifepristone does not “treat” a “serious or life-threatening illness.” Pregnancy is not an illness and killing an unborn child is not treatment.
Second, chemical abortion does not now, and certainly did not then, provide a “meaningful therapeutic benefit . . . over existing treatments.” As a 2006 <a href="https://advancingamericanfreedom.com/mifepristone-resource-congressional-staff-report-the-fda-and-ru-486-lowering-the-standard-for-womens-health/" target="_blank" rel="noopener">congressional report</a> on mifepristone’s approval explained, “it appears that no concurrently-controlled trials comparing medical and surgical abortion were required by FDA, because the Agency already knew that medical abortion—i.e., abortion by RU-486—is unambiguously inferior to surgical abortion with respect to safety and effectiveness.”
Nor, as the same report lays out in detail, did the FDA rely on studies of sufficient rigor to meet Subpart H’s requirements.
How could the FDA so blatantly disregard its own rules? Because the approval of chemical  abortion was <a href="https://humanlifereview.com/playing-politics-with-the-abortion-pill-a-quarter-century-of-abuse-of-power-at-the-fda/" target="_blank" rel="noopener">political from the start</a>.
In his <a href="https://url.avanan.click/v2/r01/___https:/advancingamericanfreedom.com/mifepristone-resource-judicial-watch-special-report-the-clinton-ru-486-files/___.YXAzOmFhZjphOm86YmM2NTQ4Zjk3MDAzZTY4MjA0NDM5NzQyZjdmNzQ4NGU6Nzo4ZDhkOjI3ZDY5MjU2MWJkOTU4OTZlNjNjYmUwMDI3ZmZjODA5NGMzNmZjYzNiYWU2NDk5MGYxZDE0MmIzNGE0Y2JiNjA6aDpUOk4" target="_blank" rel="noopener">first official act</a> as President, Bill Clinton directed HHS to promote the introduction of the abortion drug into the American market. Over the next seven years, the Clinton administration worked to have the patent rights transferred to the Population Council, which then sought the FDA’s approval.  That transfer of patent rights was necessitated by the fact that the French company that owned the patent was unwilling to introduce the drug to the American market without indemnification of liability for the harms it would foreseeably cause.
<a class="c-link" href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial" target="_blank" rel="noopener noreferrer" data-stringify-link="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial" data-sk="tooltip_parent">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout!</a>
Upon approval of mifepristone, the FDA implemented certain limitations on the drug’s prescription to provide at least some protection to women. <a href="https://url.avanan.click/v2/r01/___https:/storage.courtlistener.com/recap/gov.uscourts.txnd.370067/gov.uscourts.txnd.370067.137.0_20.pdf___.YXAzOmFhZjphOm86YmM2NTQ4Zjk3MDAzZTY4MjA0NDM5NzQyZjdmNzQ4NGU6Nzo3MWI3OjEzNTE0ZGZhZjY0OTJkZGEwMzg2NmU3ZDRhYjFjYjlhZjQ2MDZiMzc2MzEyMDEzZjNkMmQ4NzgyYTJhOTEwNDY6aDpUOk4" target="_blank" rel="noopener">Specifically,</a> the abortion drug could only be prescribed to women who were less than seven weeks pregnant, women were required to visit the doctor three times, and abortionists were required to report all adverse events.
These restrictions did not make mifepristone safe, but they did reduce the risk of harm to women. For example, in-person consultations provided women with necessary procedures, such as ultrasounds, critical for recognizing ectopic pregnancies, which, if left untreated, are deadly.
In March 2016, the Obama FDA significantly <a href="https://url.avanan.click/v2/r01/___https:/storage.courtlistener.com/recap/gov.uscourts.txnd.370067/gov.uscourts.txnd.370067.137.0_20.pdf___.YXAzOmFhZjphOm86YmM2NTQ4Zjk3MDAzZTY4MjA0NDM5NzQyZjdmNzQ4NGU6NzozMzQ4OjU0ZDdkY2E2NzEzOWExMDlmZTU0NzVjM2QwMTdkZmFjOGE1YzcxNzc3NTU2OWI3OTg4NzIxOGFlMjJhNjViYTc6aDpUOk4" target="_blank" rel="noopener">reduced</a> these protections, now referred to as a Risk Evaluation and Mitigation Strategy (REMS). Under the updated REMS, women could be prescribed mifepristone for abortions up to 10 weeks’ gestation and only needed to visit a doctor once, non-doctors were allowed to prescribe chemical abortions, and abortionists were only required to report fatal adverse events.
In 2021, the FDA “<a href="https://url.avanan.click/v2/r01/___https:/storage.courtlistener.com/recap/gov.uscourts.txnd.370067/gov.uscourts.txnd.370067.137.0_20.pdf___.YXAzOmFhZjphOm86YmM2NTQ4Zjk3MDAzZTY4MjA0NDM5NzQyZjdmNzQ4NGU6Nzo2ZGViOmVkNjQ0OWNmMjVmNWFiNzUyNDhjYzZkNGE2NzAxODU0ZTkyNjcwNGIzMDIzOWQyMGI0YWY5YjY2NjJkMDdlMzI6aDpUOk4" target="_blank" rel="noopener">removed</a> the ‘in-person dispensing requirement’” altogether.
In 2023, <a href="https://url.avanan.click/v2/r01/___https:/nrlc.org/nrlnewstoday/2024/03/guttmacher-says-abortions-increased-after-dobbs/___.YXAzOmFhZjphOm86YmM2NTQ4Zjk3MDAzZTY4MjA0NDM5NzQyZjdmNzQ4NGU6NzpjZjQ2OmNhNDQ5Mzc5ZWY2OGZhYjg5MjYyMDNlM2RhZGU5NGU3MDU2YjE3M2YwMzlhNjQwMGYwMmYzNmI2MTkyMWIyMDg6aDpUOk4" target="_blank" rel="noopener">63%</a> of abortions were chemical rather than surgical, and <a href="https://url.avanan.click/v2/r01/___https:/www.guttmacher.org/report/stability-number-abortions-2023-2024-us-states-without-total-bans-masks-major-shifts-access___.YXAzOmFhZjphOm86YmM2NTQ4Zjk3MDAzZTY4MjA0NDM5NzQyZjdmNzQ4NGU6Nzo0N2Q2OjFlMjhlNWE0NzQxODVlNWZiZDQ4YThmZWE5ODIzNTFkZTNlOWM3NWM5MGY4ZjJlOWI2NzY2YmM3ZGJmNDM4ZjI6aDpUOk4" target="_blank" rel="noopener">tens of thousands</a> of chemical abortions were shipped into pro-life states in 2024.
The FDA’s review of the dangers of mifepristone to women’s health is long overdue. A recent study by the Ethics and Public Policy Center suggesting that the adverse event rate for chemical abortion is much higher than FDA data suggests, is only the most recent in two and a half decades of evidence that the FDA’s approval of the drug is dangerous for women.
Armed with this and other data, the heads of HHS and the FDA have legal authority to <a href="https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-314/subpart-D/section-314.150" target="_blank" rel="noopener">call for a hearing</a> to determine whether the FDA’s initial approval of mifepristone should be withdrawn. This would be an important step toward removing dangerous chemical abortion drugs from the market, and allow the agency to delay approval of any other generic forms of mifepristone currently being considered.
For the past 25 years, mifepristone has been used to terminate innocent human life while injuring and harming women for life. The abortion drug’s reckoning is long overdue. The FDA’s recently announced review is a good first step, but pro-life Americans cannot rest until the dangerous chemical abortion pill is taken off the market and pre-born Americans are safe from its harms.
Marc Wheat is general counsel for Advancing American Freedom.
<div>
<div id="post-body-text" class="css-1ec96ji">
<div class="eo63h7k0 css-1mqhe4y">
The views expressed in this piece are those of the author and do not necessarily represent those of The Daily Wire.
</div>
</div>
</div>

HHS Secretary Kennedy Holds News Conference On Synthetic Dyes In Food Supply

The FDA’s Review Of Abortion Drugs Is Long Overdue

A coalition of pro-life advocates led by Live Action President Lila Rose on Friday urged Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary to reverse the recent approval of an abortion drug. 
Over two dozen pro-life advocates petitioned the FDA following the agency&#8217;s Tuesday approval of Evita Solutions’ generic version of mifepristone, the drug used in over 60% of all abortions. The signatories say that instead of approving new life-ending drugs, the FDA should completely remove mifepristone from the market. 
“We urge you, in the strongest possible terms, to reverse this dangerous approval immediately,&#8221; the coalition wrote, according to a <a href="https://dw-wp-production.imgix.net/2025/10/FDA-Coalition-Letter_-Abortion-Pill-10.3.2025-1.pdf">copy of the letter</a> obtained by The Daily Wire. &#8220;Rather than expanding the license for these drugs, the FDA should acknowledge the clear evidence of harm and withdraw mifepristone from the market.&#8221;
“Every abortion is a violation of human rights, and every life lost is an irreplaceable son or daughter. The federal government must stop enabling this violence under the false banner of ‘healthcare,’” they added. 
Signers of the letter included Ethics and Public Policy Center President Ryan Anderson, Students for Life President Kristan Hawkins, and Concerned Women for America CEO Penny Nance.
On Friday, White House Press Secretary Karoline Leavitt said that the administration did not endorse the drug, but was required by law to approve Evita’s application because it was a generic offering of a drug already offered by two other pharmaceutical companies. 
The letter to Kennedy also laid out the brutal process that takes place after a mother takes a chemical abortion pill. 
“A chemical abortion consists of a two-step process. First, a pregnant mother will take mifepristone to starve her preborn child to death. Next, she will take misoprostol to induce labor contractions and deliver the baby&#8217;s dead body. At this stage in the first trimester, children developing in the womb already have a detectable heartbeat and brainwaves, and are beginning to move their arms and legs,” the coalition wrote. 
The coalition said that the approval contradicted a recent commitment from Kennedy to study the dangers of mifepristone. 
“Yet rather than pausing to examine the mounting evidence showing the harmful effects of mifepristone, the FDA has chosen to expand access to a drug that has already killed millions of preborn children and harmed countless women, undermining the very commitment that the Secretary publicly made to protect patients,” they wrote. 
Chemical abortions account for about two-thirds of all abortions in the United States and have ended the lives of at least 7.5 million unborn babies. At the same time, the mothers who take the pills often experience additional medical complications like hemorrhaging and sepsis. Studies showing the dangers of the drug have been manipulated to hide the harm, the coalition said. 
The decision has already triggered outrage from many Republican lawmakers. Senator Josh Hawley (R-MO) said he had completely lost faith in the FDA over the move, while over a dozen Republican representatives <a href="https://www.dailywire.com/news/republicans-demand-rfk-fire-rogue-actors-at-fda-who-approved-abortion-drug?author=Leif+Le+Mahieu&amp;category=News&amp;elementPosition=1&amp;row=0&amp;rowType=Vertical+List&amp;title=Republicans+Demand+RFK+Fire+%E2%80%98Rogue+Actors%E2%80%99+At+FDA+Who+Approved+Abortion+Drug">sent a letter</a> on Friday telling Kennedy to fire the “rogue actors” at the agency who approved the lethal drug.

Great American Farmers Market 2025

‘Every Abortion Is A Violation Of Human Rights’: Pro-Life Advocates Demand FDA Yank Abortion Drug

The U.S. Food and Drug Administration said on Friday it has launched a new pilot program to speed up the review process for generic drugs that are tested and manufactured entirely in the United States.
The program is designed to encourage companies to invest in domestic drug production and research by offering faster approvals for products made with U.S.-sourced ingredients and tested within the country.
Earlier this week, the FDA held a public meeting to discuss its broader efforts to support U.S. pharmaceutical manufacturing, including the PreCheck program, which aims to help set up high-priority drug facilities more quickly.
The FDA said these steps will help strengthen the U.S. drug supply chain and bring high-quality, U.S.-made generic drugs to market more quickly.
More than half of the pharmaceuticals distributed in the United States are made overseas, according to the health regulator.
As of 2025, only 9% of companies that produce the key ingredients in drugs &#8211; known as active pharmaceutical ingredients &#8211; are based in the U.S., compared to 22% in China and 44% in India, the FDA said.
<a href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout</a>
&#8220;Over-reliance on foreign drug manufacturing and testing creates risks both to national security and patient access, and undermines investments in U.S. research, manufacturing and production,&#8221; said George Tidmarsh, Director of FDA&#8217;s Center for Drug Evaluation and Research.
&#8220;It also slows down reviews and costs taxpayers more money,&#8221; he added.
The FDA also noted many important studies used to approve drugs &#8211; including tests to show that generic drugs work the same as brand-name ones &#8211; are now often done outside the U.S., which is weakening the country&#8217;s ability to lead in drug research and development.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shailesh Kuber)

Prescription drugs

FDA Launches Pilot Program To Fast-Track Review Of Generic Drugs Made In U.S.

Trump Administration

A group of 13 House Republicans led by North Carolina Congressman Mark Harris demanded Friday that Health and Human Services Secretary Robert F. Kennedy Jr. fire the bureaucrats responsible for the FDA’s “alarming” approval of a new abortion pill, according to a letter obtained by The Daily Wire. 
Harris told Kennedy that the FDA’s <a href="https://www.dailywire.com/news/pro-lifers-demand-answers-from-trump-admin-after-shocking-abortion-pill-approval?author=Leif+Le+Mahieu&amp;category=News&amp;elementPosition=2&amp;row=0&amp;rowType=Vertical+List&amp;title=Pro-Lifers+Demand+Answers+From+Trump+Admin+After+%E2%80%98Shocking%E2%80%99+Abortion+Pill+Approval">approval</a> of Evita Solutions’ generic mifepristone, the drug used in over 60% of all abortions, ran contrary to the Trump administration’s pro-life record. Harris and his co-signers suggested that “rogue actors” in the FDA were responsible for the decision. 
“The approval of a generic version of this dangerous drug not only contradicts the announced review but also runs directly counter to this Administration’s stated pro-life agenda,” the lawmakers <a href="https://dw-wp-production.imgix.net/2025/10/10.3.25-Letter-to-Sec-Kennedy-on-Abortion-Pill-Approval.pdf">wrote</a>. “It is clear that rogue actors within the FDA are working to undermine both the sanctity of life and the Administration’s commitment to protecting it.”
They said that Kennedy should look at removing the officials responsible for the decision. 
“For this reason, we respectfully urge that you consider the director of the Office of Generic Drugs, the director of the Center for Drug Evaluation and Research, and other bureaucrats responsible for this reckless decision as part of your reduction-in-force evaluations,” he wrote. 
Signing onto the letter were Reps. Josh Brecheen (OK), Keith Self (Texas), Eli Crane (AZ), Paul Gosar (AZ), Chip Roy (Texas), Mary Miller (IL), Andy Biggs (AZ), Barry Moore (AL), Scott Perry (PA), Ralph Norman (SC), Sheri Biggs (SC), and Ben Cline (VA). 
Mifepristone works by starving an unborn child to death by cutting it off from the necessary nutrients provided by its mother. A different drug is then taken to induce labor and expel the deceased baby from the mother. 
Harris said that removing the officials responsible for the decision would send a message that the administration still believes in defending innocent life. 
“As stewards of the taxpayers’ trust and defenders of the unborn, we must ensure that no federal office operates in open defiance of our values or the administration’s pro-life commitments. This is a critical moment to send a clear message that the lives of the unborn and the health of women will not be compromised by bureaucratic mismanagement or ideological activism.
Commenting on the approval, Health and Human Services Communications Director Andrew Nixon told The Daily Wire that the FDA “has very limited discretion in deciding whether to approve a generic drug. By law, the Secretary of Health and Human Services must approve an application if it demonstrates that the generic drug is identical to the brand-name drug.”
Nixon added that applicants for generic drugs do not need to submit independent evidence proving safety and efficacy. He also noted that HHS is conducting a review of the “reported adverse effects” of mifepristone.
Only two other drug companies, Danco Labs and Genbiopro, were previously approved to distribute the life-ending drug. The FDA wrote to Evita Solutions on September 30 that it had “concluded that adequate information has been presented to demonstrate that the drug meets the requirements for approval.”
The announcement shocked pro-life advocates, who have continued to press for action to crack down on the widespread distribution of abortion pills across the country.

MixCollage-03-Oct-2025-09-31-AM-5086

Republicans Demand RFK Fire ‘Rogue Actors’ At FDA Who Approved Abortion Drug

Pro-life advocates are demanding answers from the White House after the FDA approved a new abortion pill in a “shocking” decision earlier this week.
The FDA on Tuesday gave <a href="https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/216616s000ltr.pdf">approval</a> for Evita Solutions to distribute mifepristone, a drug that is used to end the life of an unborn child in up to 63% of all abortions. After a pregnant woman takes mifepristone, her unborn child is cut off from the nutrients it needs to survive and is effectively starved to death. A different drug is then taken to induce labor and expel the deceased baby from the mother. 
The fatal drug has been increasingly available after the Biden administration allowed it to be mailed by doctors. Leftist activists ship the drugs illegally across the country with impunity. 
Senator Josh Hawley (R-MO) called the approval “shocking” and said he had lost faith in FDA leadership. 
“This is shocking. FDA has just approved ANOTHER chemical abortion drug, when the evidence shows chemical abortion drugs are dangerous and even deadly for the mother. And of course 100% lethal to the child,” Hawley <a href="https://x.com/HawleyMO/status/1973801164052574259">wrote</a> on X. 
“FDA had promised to do a top-to-bottom safety review of the chemical abortion drug, but instead they’ve just greenlighted new versions of it for distribution. I have lost confidence in the leadership at FDA,” he added. 
Rep. Mark Harris (R-NC) also questioned the move.
&#8220;Wow! The FDA just approved a generic version of the abortion pill, Mifepristone, a drug that ends a baby&#8217;s life 100% of the time and harms mothers. The FDA announced a new safety study just days ago, so why this new move now?&#8221; he <a href="https://x.com/RepMarkHarrisNC/status/1973841437730222548">wrote</a> on X.
Only two other drug companies, Danco Labs and Genbiopro, were previously approved to distribute the life-ending drug. The FDA wrote to Evita Solutions on September 30 that it had “concluded that adequate information has been presented to demonstrate that the drug meets the requirements for approval.”
Evita Solutions says on its <a href="https://www.evitasolutionsllc.com">website</a> that “medical abortion care is rife with medically unnecessary restrictions and social stigma in the United States” and that it “believes that all people should have access to safe, affordable, high-quality, effective, and compassionate abortion care, regardless of their race, sex, gender, age, sexuality, income, or where they live.”
Evita said that it expected to have the life-ending drug available by January 2026.
&#8220;Evita Solutions is now the third manufacturer (the second generic manufacturer) with FDA approval.  Availability of our product will expand patients’ options for medication abortion with an affordable product backed by decades of safe use,&#8221; it said in a statement.
In response to questions about the drug’s approval, Health and Human Services Communications Director Andrew Nixon told The Daily Wire that the FDA “has very limited discretion in deciding whether to approve a generic drug. By law, the Secretary of Health and Human Services must approve an application if it demonstrates that the generic drug is identical to the brand-name drug.”
Nixon added that applicants for generic drugs do not need to submit independent evidence proving safety and efficacy. 
“HHS is conducting a study of the reported adverse effects of mifepristone to ensure the FDA’s risk mitigation program for the drug is sufficient to protect women from unstated risks,” Nixon added. “The FDA does not endorse any drug product and directs prescribers to follow all labeling.”
The decision is already drawing backlash from pro-life advocates who have long warned about the dangers of the drug. Kelsey Pritchard, the director of state affairs for SBA Pro-Life America, called the decision “reckless.”
“This does nothing to help and fix the problem that we have with abortion drugs and mail-order abortion drugs, and instead puts a cheap drug on the market so that more unborn lives are taken and more women and girls end up in the ER,” she told The Daily Wire. 
Pritchard said that the Trump administration should reinstate restrictions on the mailing of mifepristone that the Biden administration loosened. 
“This decision is not MAGA. It is not MAHA, adding a new life ending drug to the market doesn&#8217;t make America greater or healthier, and this is not something that we would expect, especially at this time,” she added, calling for pro-life Republicans to call out the decision. 
Last month, HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary told Republican attorneys general that they were studying the safety of mifepristone. Some studies have shown that the drug is not only fatal to the unborn child but can also bring serious health risks to the mother.

Senate Hearing Examines AI Industry’s Use Of Copyrighted Works To Train AI Models

Pro-Lifers Demand Answers From Trump Admin After ‘Shocking’ Abortion Pill Approval

The U.S. Food and Drug Administration (FDA) announced on Tuesday evening that it&#8217;s cracking down on deceptive pharmaceutical ads, issuing thousands of warning letters and about 100 cease-and-desist notifications.
“For far too long, the FDA has permitted misleading drug advertisements, distorting the doctor-patient relationship and creating increased demand for medications regardless of clinical appropriateness,” FDA Commissioner Dr. Marty Makary said in a statement. “Drug companies spend up to 25% of their budget on advertising. Those billions of dollars would be better spent on lowering drug prices for everyday Americans.”
A press release from the agency said current law requires pharma ads to &#8220;present a fair balance between a product’s risks and benefits; avoid exaggerating benefits; not create a misleading overall impression; properly disclose financial relationships; and include information regarding major side effects and contraindications.&#8221;
That rule, which the FDA did not adequately enforce during the Biden years, will be &#8220;aggressively&#8221; enforced now, the release says. Additionally, the FDA is closing the “adequate provision” loophole created in 1997, which companies have used to &#8220;conceal critical safety risks in broadcast and digital ads, fueling inappropriate drug use and eroding public trust.&#8221;
Television ads are not the only promotional content being scrutinized and regulated. Social media posts, which often feature an influencer talking up the drug, rarely mention &#8220;potential harms,&#8221; or they fail to disclose that the influencers are being paid.
&#8220;[W]hile 100% of pharmaceutical social media posts highlight drug benefits, only 33% mention potential harms,&#8221; the FDA said, citing a 2024 review in the Journal of Pharmaceutical Health Services Research. &#8220;Moreover, 88% of advertisements for top-selling drugs are posted by individuals and organizations that fail to adhere to the FDA fair balance guidelines.&#8221;
In the thousands of letters sent to drug companies, the FDA warns, &#8220;You are hereby directed to remove any noncompliant advertising and bring all promotional communications into compliance.&#8221;
&#8220;This notice also serves to demand compliance with the [Federal Food, Drug, and Cosmetic] Act and FDA implementing regulations and requires companies to remove any and all DTC (direct-to-consumer) prescription drug advertising that violates the law,&#8221; the letter adds.
Robert F. Kennedy Jr. &#8212; the head of Health and Human Services (HHS), which oversees the FDA &#8212; has long been a critic of Big Pharma ads. He said in a statement issued Tuesday that &#8220;pharmaceutical ads hooked this country on prescription drugs.&#8221;
&#8220;We will shut down that pipeline of deception and require drug companies to disclose all critical safety facts in their advertising,&#8221; he continued. &#8220;Only radical transparency will break the cycle of overmedicalization that drives America’s chronic disease epidemic.”
While Kennedy was running for president in 2024, before he endorsed President Donald Trump, he said he would &#8220;issue an executive order banning pharmaceutical advertising on television.&#8221;
&#8220;We are one of only two countries in the world that allow pharmaceutical companies to advertise directly to consumers on television,&#8221; RFK Jr. said on X in 2024. &#8220;Not surprisingly, Americans consume more pharmaceutical products than anyone else on the planet.&#8221;

Trump FDA Announces Major Crackdown On ‘Misleading’ Pharma Ads

Big Pharma

Menu

FDA